LM 6.5: Disorders of Hemostasis Flashcards

1
Q

what is a hypercoagulable state?

A

a tendency to thrombus under circumstances that would not cause thrombosis in a normal individual

can be inherited or acquired

can effect the venous &/or arterial circulations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are thrombogenic risk factors?

A
  • damage to the blood vessel wall
  • activation of platelets
  • activation of blood coagulation
  • inhibition of thrombolysis and status of blood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are protective mechanisms?

A

protect against a hypercoagulable state

  • intact endothelium
  • normal levels of antithrombin
  • normal protein C&S levels
  • normal function of the fibrinolytic pathway
  • clearance of activation products of the coagulation pathway by the liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is arterial thrombogenesis?

A

platelets play the major role

usually develop in a diseased vessel where the blood is exposed to the damaged endothelium and subendothelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is venous thrombogenesis?

A

forms in areas of slowed or disturbed blood flow

thrombophilias may play a role

may occur in a healthy vessel

platelets play a secondary role

environmental factors play a significant role

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

which diseases are inherited thrombophilias?

A

they are all hyper coagulable states

  • antithrombin deficiency
  • protein C&S deficiency
  • activated protein C resistance
  • prothrombin G20210A
  • hyperhomocystinemia
  • hypoplasminemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what causes activated protein C resistance?

A

due to point mutation in the factor V gene, factor V Leiden

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is antithrombin deficiency?

A

AT is produced by the liver and it inactivates coagulation factors, thrombin, Xa, IXa, XIa, and XIIa

factors 2,7,9,10,11,12

type I: deficiency of the protein
type II: reduced function but normal quantity of AT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

which coagulation factors does AT inactivate?

A

thrombin, Xa, IXa, XIa, and XIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the inheritance pattern of AT deficiency?

A

autosomal dominant

most patients are heterozygous (40-70% of normal AT levels)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are protein C&S?

A

they are vitamin K dependent tproteins

produced by the liver

they inactivate factors V and VIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how is protein C&S deficiency inherited?

A

autosmal dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is protein C&S deficiency?

A

type I: deficiency of the quantity of the protein

type II: deficiency in the function of the protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is activated protein C resistance?

A

point mutation in factor V gene causes abnormal factor V protein

abnormal factor V doesn’t allow activated C protein to lock onto it and neutralize the effects of factor V

so the coagulation cascade just keeps going = increased clotting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are disorders of fibrinolysis?

A

reduced plasmin formation

can cause venous or arterial thrombosis but it’s not common

hypoplasminogenemia is an uncommon cause of reduced fibrinolytic activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are some of the acquired hypercoagulable risk factors?

A
  • trauma
  • smoking
  • malignancy
  • estrogen therapy
  • inflammatory bowel disease
  • antiphospholipid antibodies
17
Q

what is APA?

A

antiphospholipid antibodies

autoimmune disorder

18
Q

what are some common phospholipid antibodies?

A

lupus anticoagulant

anticardioplipin antibodies

they can prolong the aPTT despite being associated with increased risk for both arterial and venous clot formation